92 related articles for article (PubMed ID: 7078638)
21. Maternal immune system during human gestation.
Gall SA
Semin Perinatol; 1977 Apr; 1(2):119-33. PubMed ID: 224506
[No Abstract] [Full Text] [Related]
22. Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas.
Liao SK; Horton L; Flahart RE; O'Rear L; Crumpacker D; Imbaratto JW; Yannelli JR; Robinson RR; Oldham RK
Hum Antibodies Hybridomas; 1990; 1(2):66-76. PubMed ID: 2103354
[TBL] [Abstract][Full Text] [Related]
23. Isolation of isotype variants from hybridomas producing monoclonal antibodies to urothelial cancer associated antigens.
Lovric J; Decken K; Ebert T; Schmitz-Dräger BJ
Investig Urol (Berl); 1994; 5():71-5. PubMed ID: 7719324
[No Abstract] [Full Text] [Related]
24. Human IgG3 monoclonal antibody directed to an unbranched repeating type 2 chain (Gal beta 1----4GlcNAc beta 1----3Gal beta 1----4GlcNAc beta 1----3Gal beta 1----R) which is highly expressed in colonic and hepatocellular carcinoma.
Miyake M; Kohno N; Nudelman ED; Hakomori S
Cancer Res; 1989 Oct; 49(20):5689-95. PubMed ID: 2551493
[TBL] [Abstract][Full Text] [Related]
25. IgG2a monoclonal antibodies inhibit human tumor growth through interaction with effector cells.
Herlyn D; Koprowski H
Proc Natl Acad Sci U S A; 1982 Aug; 79(15):4761-5. PubMed ID: 6289317
[TBL] [Abstract][Full Text] [Related]
26. The antibody-independent cytotoxic activity of normal circulating human leucocytes. I. Lysis of target cells by monocytes and neutrophils in a non-phagocytic pathway.
Banerjee D; Fernando L; Sklar S; Richter M
Immunology; 1981 Sep; 44(1):97-107. PubMed ID: 7275189
[TBL] [Abstract][Full Text] [Related]
27. Antibody-dependent cellular cytotoxicity mediated by murine lymphocytes activated in recombinant interleukin 2.
Shiloni E; Eisenthal A; Sachs D; Rosenberg SA
J Immunol; 1987 Mar; 138(6):1992-8. PubMed ID: 3493293
[TBL] [Abstract][Full Text] [Related]
28. Antibody-dependent cell-mediated cytotoxicity by human lymphocytes. II. Comparison with polymorphonuclear leukocytes against erythrocyte and nucleated target cells.
Fuson EW; Shaw MW; Hubbard RA; Sugantharaj DG; Lamon EW
Exp Hematol; 1981 Feb; 9(2):197-206. PubMed ID: 7238651
[TBL] [Abstract][Full Text] [Related]
29. A mechanism for neutrophil-mediated lysis of human neuroblastoma cells.
Barker E; Reisfeld RA
Cancer Res; 1993 Jan; 53(2):362-7. PubMed ID: 8417829
[TBL] [Abstract][Full Text] [Related]
30. Generation, selection and preclinical characterization of an Fc-optimized FLT3 antibody for the treatment of myeloid leukemia.
Hofmann M; Große-Hovest L; Nübling T; Pyż E; Bamberg ML; Aulwurm S; Bühring HJ; Schwartz K; Haen SP; Schilbach K; Rammensee HG; Salih HR; Jung G
Leukemia; 2012 Jun; 26(6):1228-37. PubMed ID: 22289926
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal antiidiotypic antibodies related to a murine oncofetal bladder tumor antigen induce specific cell-mediated tumor immunity.
Lee VK; Harriott TG; Kuchroo VK; Halliday WJ; Hellström I; Hellström KE
Proc Natl Acad Sci U S A; 1985 Sep; 82(18):6286-90. PubMed ID: 3875859
[TBL] [Abstract][Full Text] [Related]
32. Hypothesis: macrophages as effector cells for human tumor destruction mediated by monoclonal antibody.
Steplewski Z; Herlyn D; Maul G; Koprowski H
Hybridoma; 1983; 2(1):1-5. PubMed ID: 6678794
[No Abstract] [Full Text] [Related]
33. Cell binding and tumor inhibiting functions of a new antihuman melanoma murine monoclonal antibody.
Abdel-Wahab Z; Darrow T; Vervaert CE; Crowley NJ; Seigler HF
Mol Biother; 1991 Sep; 3(3):163-9. PubMed ID: 1768367
[TBL] [Abstract][Full Text] [Related]
34. Monoclonal antibody-directed effector cells selectively lyse human melanoma cells in vitro and in vivo.
Schulz G; Bumol TF; Reisfeld RA
Proc Natl Acad Sci U S A; 1983 Sep; 80(17):5407-11. PubMed ID: 6577434
[TBL] [Abstract][Full Text] [Related]
35. Polymorphonuclear leukocytes in antibody-dependent cellular cytotoxicity.
Gale RP; Zighelboim J
J Immunol; 1975 Mar; 114(3):1047-51. PubMed ID: 1167565
[TBL] [Abstract][Full Text] [Related]
36. [Role of the neutrophils in the pathogenesis of malignant growth].
Kashulina AP; Tereshchenko IP
Eksp Onkol; 1985; 7(6):3-9. PubMed ID: 3910404
[TBL] [Abstract][Full Text] [Related]
37. Effect of immunization against human chorionic gonadotropin (hCG) on transplantation of Yoshida ascitic tumour.
Bernardini A; Corbino N; Rapisarda Proto G; Iacona G; Stivala F
Microbiologica; 1982 Oct; 5(4):383-8. PubMed ID: 7154977
[TBL] [Abstract][Full Text] [Related]
38. Effect of kinase inhibitors on the therapeutic properties of monoclonal antibodies.
Duong MN; Matera EL; Mathé D; Evesque A; Valsesia-Wittmann S; Clémenceau B; Dumontet C
MAbs; 2015; 7(1):192-8. PubMed ID: 25523586
[TBL] [Abstract][Full Text] [Related]
39. Targeting of human breast cancer by a bispecific antibody directed against two tumour-associated antigens: ErbB-2 and carcinoembryonic antigen.
Dorvillius M; Garambois V; Pourquier D; Gutowski M; Rouanet P; Mani JC; Pugnière M; Hynes NE; Pèlegrin A
Tumour Biol; 2002; 23(6):337-47. PubMed ID: 12677091
[TBL] [Abstract][Full Text] [Related]
40. Potentiation of tumor lysis by a bispecific antibody that binds to CA19-9 antigen and the Fc gamma receptor expressed by human large granular lymphocytes.
de Palazzo IG; Gercel-Taylor C; Kitson J; Weiner LM
Cancer Res; 1990 Nov; 50(22):7123-8. PubMed ID: 2146012
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
